Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders
Primus Che Chi,Esther Awuor Owino,Irene Jao,Fredrick Olewe,Bernhards Ogutu,Philip Bejon,Melissa Kapulu,Dorcas Kamuya,Vicki Marsh,Abdirahman I. Abdi,Yonas Abebe,Agnes Audi,Peter Billingsley,Peter C. Bull,Mainga Hamaluba,Zaydah de Laurent,Susanne H. Hodgson,Stephen Hoffman,Eric James,Gathoni Kamuyu,Silvia Kariuki,Nelson Kibinge,Rinter Kimathi,Sam Kinyanjui,Cheryl Kivisi,Nelly Koskei,Mallika Imwong,Brett Lowe,Johnstone Makale,Kevin Marsh,Khadija Said Mohammed,Moses Mosobo,Sean C. Murphy,Linda Murungi,Jennifer Musyoki,Michelle Muthui,Jedidah Mwacharo,Daniel Mwanga,Joyce Mwongeli,Francis Ndungu,Maureen Njue,Patricia Njuguna,George Nyangweso,Domitila Kimani,Joyce M. Ngoi,Janet Musembi,Omar Ngoto,Edward Otieno,Faith Osier,James Oloo,Donwilliams Omuoyo,John Ongecha,Martin O. Ongas,Michael Ooko,Jimmy Shangala,Betty Kim Lee Sim,Joel Tarning,James Tuju,Juliana Wambua,Thomas N. Williams,Markus Winterberg,
DOI: https://doi.org/10.1186/s13063-021-05455-7
IF: 2.728
2021-07-26
Trials
Abstract:Abstract Background Human infection studies (HIS) that involve deliberately infecting healthy volunteers with a pathogen raise important ethical issues, including the need to ensure that benefits and burdens are understood and appropriately accounted for. Building on earlier work, we embedded social science research within an ongoing malaria human infection study in coastal Kenya to understand the study benefits and burdens experienced by study stakeholders in this low-resource setting and assess the wider implications for future research planning and policy. Methods Data were collected using qualitative research methods, including in-depth interviews (44), focus group discussions (10) and non-participation observation. Study participants were purposively selected (key informant or maximal diversity sampling), including volunteers in the human infection study, study staff, community representatives and local administrative authorities. Data were collected during and up to 18 months following study residency, from sites in Coastal and Western Kenya. Voice recordings of interviews and discussions were transcribed, translated, and analysed using framework analysis, combining data- and theory-driven perspectives. Findings Physical, psychological, economic and social forms of benefits and burdens were experienced across study stages. Important benefits for volunteers included the study compensation, access to health checks, good residential living conditions, new learning opportunities, developing friendships and satisfaction at contributing towards a new malaria vaccine. Burdens primarily affected study volunteers, including experiences of discomfort and ill health; fear and anxiety around aspects of the trial process, particularly deliberate infection and the implications of prolonged residency; anxieties about early residency exit; and interpersonal conflict. These issues had important implications for volunteers’ families, study staff and the research institution’s reputation more widely. Conclusion Developing ethically and scientifically strong HIS relies on grounded accounts of volunteers, study staff and the wider community, understood in the socioeconomic, political and cultural context where studies are implemented. Recognition of the diverse, and sometimes perverse, nature of potential benefits and burdens in a given context, and who this might implicate, is critical to this process. Prior and ongoing stakeholder engagement is core to developing these insights.
medicine, research & experimental